FDA Approved: TRUVADA — Supplemental Application (Gilead Sciences, Inc)

View source ↗

Summary

FDA approved a supplemental application for Truvada (emtricitabine/tenofovir disoproxil fumarate) filed by Gilead Sciences, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

SUPPL AP for TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)